Literature DB >> 34223934

Aristolochic acid IVa forms DNA adducts in vitro but is non-genotoxic in vivo.

Jingjing Wan1, Ruixue Chen1, Zhou Yang2, Jing Xi1, Yiyi Cao1, Yu Chen3, Xinyu Zhang4, Yang Luan5.   

Abstract

Aristolochic acids (AAs) are a family of natural compounds with AA I and AA II being known carcinogens, whose bioactivation causes DNA adducts formation. However, other congeners have rarely been investigated. This study aimed to investigate genotoxicity of AA IVa, which differs from AA I by a hydroxyl group, abundant in Aristolochiaceae plants. AA IVa reacted with 2'-deoxyadenosine (dA) and 2'-deoxyguanosine (dG) to form three dA and five dG adducts as identified by high-resolution mass spectrometry, among which two dA and three dG adducts were detected in reactions of AA IVa with calf thymus DNA (CT DNA). However, no DNA adducts were detected in the kidney, liver, and forestomach of orally dosed mice at 40 mg/kg/day for 2 days, and bone marrow micronucleus assay also yielded negative results. Pharmacokinetic analyses of metabolites in plasma indicated that AA IVa was mainly O-demethylated to produce a metabolite with two hydroxyl groups, probably facilitating its excretion. Meanwhile, no reduced metabolites were detected. The competitive reaction of AA I and AA IVa with CT DNA, with adducts levels varying with pH of reaction revealed that AA IVa was significantly less reactive than AA I, probably by hydroxyl deprotonation of AA IVa, which was explained by theoretical calculations for reaction barriers, energy levels of the molecular orbits, and charges at the reaction sites. In brief, although it could form DNA adducts in vitro, AA IVa was non-genotoxic in vivo, which was attributed to its low reactivity and biotransformation into an easily excreted metabolite rather than bioactivation.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Aristolochic acid IVa; DNA adducts; Genotoxicity; Metabolism; Micronucleus assay; Theoretical calculations

Mesh:

Substances:

Year:  2021        PMID: 34223934     DOI: 10.1007/s00204-021-03077-1

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  35 in total

1.  Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.

Authors:  Volker M Arlt; Kateřina Levová; František Bárta; Zhanquan Shi; James D Evans; Eva Frei; Heinz H Schmeiser; Daniel W Nebert; David H Phillips; Marie Stiborová
Journal:  Chem Res Toxicol       Date:  2011-09-29       Impact factor: 3.739

2.  Assessment of Pig-a, Micronucleus, and Comet Assay Endpoints in Tg.RasH2 Mice Carcinogenicity Study of Aristolochic Acid I.

Authors:  Ruixue Chen; Changhui Zhou; Yiyi Cao; Jing Xi; Toko Ohira; Liang He; Pengcheng Huang; Xinyue You; Weiying Liu; Xinyu Zhang; Shuangcheng Ma; Tianpei Xie; Yan Chang; Yang Luan
Journal:  Environ Mol Mutagen       Date:  2019-09-30       Impact factor: 3.216

3.  Time-matched analysis of DNA adduct formation and early gene expression as predictive tool for renal carcinogenesis in methylazoxymethanol acetate treated Eker rats.

Authors:  Valentina Klaus; Heinke Bastek; Katja Damme; Leonard B Collins; Roland Frötschl; Norbert Benda; Dominik Lutter; Heidrun Ellinger-Ziegelbauer; James A Swenberg; Daniel R Dietrich; Kerstin Stemmer
Journal:  Arch Toxicol       Date:  2017-03-27       Impact factor: 5.153

4.  Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells.

Authors:  Premalatha Balachandran; Feng Wei; Rui-chao Lin; Ikhlas A Khan; David S Pasco
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

5.  Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry.

Authors:  Angela K Goodenough; Herman A J Schut; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2007-02       Impact factor: 3.739

6.  Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry.

Authors:  Wan Chan; Liang Cui; Guowang Xu; Zongwei Cai
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

7.  Aristolochic acid-associated urothelial cancer in Taiwan.

Authors:  Chung-Hsin Chen; Kathleen G Dickman; Masaaki Moriya; Jiri Zavadil; Viktoriya S Sidorenko; Karen L Edwards; Dmitri V Gnatenko; Lin Wu; Robert J Turesky; Xue-Ru Wu; Yeong-Shiau Pu; Arthur P Grollman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

8.  Conformational preferences of DNA following damage by aristolochic acids: Structural and energetic insights into the different mutagenic potential of the ALI and ALII-N(6)-dA adducts.

Authors:  Preetleen Kathuria; Purshotam Sharma; Minette N Abendong; Stacey D Wetmore
Journal:  Biochemistry       Date:  2015-04-08       Impact factor: 3.162

Review 9.  Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2--a global assessment based on bibliographic sources.

Authors:  Michael Heinrich; Jennifer Chan; Stefan Wanke; Christoph Neinhuis; Monique S J Simmonds
Journal:  J Ethnopharmacol       Date:  2009-06-06       Impact factor: 4.360

10.  In Vivo Metabolism of Aristolochic Acid I and II in Rats Is Influenced by Their Coexposure.

Authors:  Alena Dedı Ková; František Bárta; Václav Martínek; Kevin Kotalík; Šárka Dušková; Jaroslav Mráz; Volker Manfred Arlt; Marie Stiborová; Petr Hodek
Journal:  Chem Res Toxicol       Date:  2020-10-20       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.